Company intelligence / Profile preview

SciPhage

Mosquera, Cundinamarca, Colombia
Ownership
Private
Development stage
Other
01

Overview

SciPhage is a Colombian biotechnology company specializing in the development of bacteriophage-based solutions to address the global crisis of antimicrobial resistance. Founded in 2014 as a spin-off from the Universidad de los Andes, the company focuses on creating organic bioproducts for animal health, human health, and aquaculture. Its flagship product, SalmoFree, is a phage cocktail designed to control Salmonella in poultry, which has demonstrated significant efficacy in large-scale field trials involving over 550,000 birds. SciPhage operates the first dedicated bacteriophage production plant in Colombia and is expanding its pipeline to include treatments for acne and aquaculture-related infections. The company's business-to-business model aims to improve food safety and agricultural productivity while reducing reliance on traditional antibiotics.

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Microbial therapyBacteriophage therapy
Industry
Biotech
02

Partnerships

BiointropicCORPAVETSENAFENAVIICA

Beyond the preview

Go deeper on SciPhage.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SciPhage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call